In the ED, initial VS were: HR 152 BP 58/33.
She was given 3L of NS with improvement in SBP to 110s, HR 130s.
Labs notable for WBC 28.3, Cr 1.8 (baseline 0.7-1.0), normal LFTs and lactate 2.2.
Upright CXR was without signs of free air/perforation.
CT abd/pelvis showed severe colitis.
Vitals prior to transfer: HR 120's, SBP 100. .
IBS 6.
Weight loss- malnutrtition [**0-0-**] 11.
Pertinent Results: ADMISSION LABS: -WBC-28.3*# RBC-4.24# Hgb-14.2# Hct-43.3# MCV-102* MCH-33.6* MCHC-32.8 RDW-12.2 Plt Ct-301# -Neuts-85* Bands-2 Lymphs-3* Monos-10 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 -PT-15.9* PTT-29.4 INR(PT)-1.5* -Glucose-142* UreaN-26* Creat-1.8* Na-135 K-3.6 Cl-90* HCO3-30 AnGap-19 -ALT-17 AST-19 AlkPhos-90 TotBili-0.4 Lipase-21 Albumin-3.5 -Calcium-7.7* Phos-3.6 Mg-1.6 -Lactate-2.2* .
DISCHARGE LABS: -WBC-3.6* RBC-2.55* Hgb-8.4* Hct-26.5* MCV-104* MCH-33.1* MCHC-31.8 RDW-12.9 Plt Ct-434 -Glucose-113* UreaN-5* Creat-0.7 Na-140 K-3.9 Cl-103 HCO3-31 AnGap-10 -Calcium-8.1* Phos-4.0 Mg-1.8 .
MICROBIOLOGY: -Blood cx ([**6-19**]): NEGATIVE -Stool C diff amplification assay ([**6-20**]): POSITIVE -Urine cx ([**6-22**]): NEGATIVE -Blood cx ([**6-29**]): NEGATIVE -Stool cx ([**6-28**]): NEGATIVE -Stool O&P ([**6-28**], [**6-29**], [**7-1**]): NEGATIVE .
ANEMIA WORKUP: TSH-1.3 calTIBC-101* VitB12-1383* Hapto-231* Ferritn-294* TRF-78* Ret Aut-1.1* .
AP CHEST X-RAY ([**6-19**]): Single AP view of the chest.
CT [**Last Name (un) **]/PELVIS WITHOUT CONTRAST ([**2159-6-19**]): Diffuse mucosal thickening of the [**Month/Day/Year 499**] is consistent with C. diff colitis.
KUB ([**2159-6-25**]): Stable colonic wall thickening consistent with the given history of c. diff colitis.
Cold forceps biopsies were performed for histology at the transverse [**Month/Day/Year 499**].
Ulceration, friability, erythema, congestion, hemorrhages and pseudomembrane in the transverse [**Month/Day/Year 499**] compatible with Severe colitis (biopsy).
# C. DIFF PANCOLITIS: Initial labs showed leukocytosis 28.3 with bandemia, CT [**Last Name (un) 103**] showed diffuse colonic mucosal thickening without e/o megacolon, C. diff assay positive.
She will complete one-month course of Vanco 125mg PO q6 hrs, and then complete long slow Vanco taper as directed by her outpatient GI Dr. [**First Name8 (NamePattern2) 553**] [**Last Name (NamePattern1) 1356**].
# HEMATOCHEZIA: Patient's HCT drifted down over the course of hospitalization, from 43 on admission to 26 on discharge.
Also checked stool cx and O/P to rule out superinfection, all negative.
HR slowly trended down over the course of hospitalization with volume repletion and pain management, 90-100 on discharge.
=============================== TRANSITION OF CARE: -Studies pending on discharge: [**Last Name (un) 499**] biopsies from flex sig  Medications on Admission: AMPHETAMINE-DEXTROAMPHETAMINE - 20 mg daily DICYCLOMINE [BENTYL] - 10 mg QID LISINOPRIL -  10 mg daily MELOXICAM [MOBIC] -  7.5 mg daily OMEPRAZOLE -  40 mg daily RANITIDINE HCL [ZANTAC] -  300 mg qHS VENLAFAXINE [EFFEXOR XR] - 150 mg [**Hospital1 **] CALCIUM CARBONATE -  600 mg (1,500 mg) [**Hospital1 **] MV-FA-CA-FE-MIN-LYCOPEN-LUTEIN [CENTRUM] - 1 tab daily PSYLLIUM HUSK [METAMUCIL] - 2 tsp [**Hospital1 **]   Discharge Medications: 1. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).
